Robert A Neff - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Robert A Neff

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

The Journal of Biological Chemistry|December 25, 2019

Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa<sub>v</sub>1.7Robert A Neff, Mack Flinspach, Alan Gibbs, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 2, 2014

Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432Brian Lord, Leah Aluisio, James R Shoblock, et al.

British Journal of Pharmacology|July 30, 2013

Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567Anindya Bhattacharya, Qi Wang, Hong Ao, et al.

British Journal of Pharmacology|May 14, 2025

Pharmacological characterisation of JNJ-78911118, a novel, centrally-penetrant, selective GluN2A antagonistBrian Lord, Sirak Simavorian, Ian Fraser, et al.

The Journal of Biological Chemistry|June 14, 2013

Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a)Natali A Minassian, Alan Gibbs, Amy Y Shih, et al.

Journal of Medicinal Chemistry|February 17, 2025

Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo ExplorationFrançois P Bischoff, Sven Van Brandt, Marcel Viellevoye, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

The Journal of Biological Chemistry|December 25, 2019

Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNa<sub>v</sub>1.7Robert A Neff, Mack Flinspach, Alan Gibbs, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 2, 2014

Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432Brian Lord, Leah Aluisio, James R Shoblock, et al.

British Journal of Pharmacology|July 30, 2013

Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567Anindya Bhattacharya, Qi Wang, Hong Ao, et al.

British Journal of Pharmacology|May 14, 2025

Pharmacological characterisation of JNJ-78911118, a novel, centrally-penetrant, selective GluN2A antagonistBrian Lord, Sirak Simavorian, Ian Fraser, et al.

The Journal of Biological Chemistry|June 14, 2013

Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a)Natali A Minassian, Alan Gibbs, Amy Y Shih, et al.

Journal of Medicinal Chemistry|February 17, 2025

Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo ExplorationFrançois P Bischoff, Sven Van Brandt, Marcel Viellevoye, et al.

Pageof 2